ECOG-ACRIN Cancer Research Group shared a post on X:
“Clinical Trial EA3202, led by Aarti Bhatia of Yale Cancer Center, aims to improve results for patients with advanced-stage Head and Neck Cancer by comparing several treatment approaches. Learn more.” .
Source: ECOG-ACRIN/X